Analysts Offer Predictions for CME Group FY2025 Earnings

CME Group Inc. (NASDAQ:CME) – Equities research analysts at Zacks Research raised their FY2025 earnings per share estimates for shares of CME Group in a research note issued on Thursday, April 10th. Zacks Research analyst T. De now forecasts that the financial services provider will post earnings per share of $10.50 for the year, up from their prior forecast of $10.40. The consensus estimate for CME Group’s current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group’s FY2026 earnings at $10.98 EPS and FY2027 earnings at $11.67 EPS.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%.

CME has been the subject of several other research reports. Erste Group Bank raised shares of CME Group to a “strong-buy” rating in a report on Monday, March 17th. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a research note on Thursday, February 13th. Citigroup lowered shares of CME Group from a “buy” rating to a “neutral” rating and decreased their price target for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $269.00 price objective on shares of CME Group in a report on Thursday, April 3rd. Finally, Keefe, Bruyette & Woods increased their target price on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a report on Friday, February 14th. Four analysts have rated the stock with a sell rating, seven have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, CME Group currently has a consensus rating of “Hold” and a consensus target price of $247.47.

CME Group Trading Up 1.2 %

Shares of CME stock opened at $261.54 on Friday. CME Group has a 1-year low of $190.70 and a 1-year high of $273.42. The company has a market cap of $94.25 billion, a price-to-earnings ratio of 27.05, a PEG ratio of 6.76 and a beta of 0.43. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The stock has a 50 day simple moving average of $255.22 and a 200-day simple moving average of $239.10.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were issued a $1.25 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a yield of 1.91%. The ex-dividend date was Friday, March 7th. CME Group’s dividend payout ratio is presently 51.71%.

Insiders Place Their Bets

In related news, COO Suzanne Sprague sold 1,500 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total value of $385,245.00. Following the transaction, the chief operating officer now directly owns 8,036 shares in the company, valued at approximately $2,063,885.88. This represents a 15.73 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Julie Winkler sold 11,592 shares of the stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the transaction, the insider now owns 21,885 shares of the company’s stock, valued at $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 27,076 shares of company stock valued at $6,871,496 in the last three months. 0.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On CME Group

Large investors have recently modified their holdings of the business. SJS Investment Consulting Inc. increased its position in shares of CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 97 shares during the last quarter. New Age Alpha Advisors LLC boosted its stake in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after buying an additional 43 shares during the period. Financial Life Planners acquired a new stake in shares of CME Group during the fourth quarter valued at about $32,000. Knuff & Co LLC acquired a new stake in shares of CME Group during the fourth quarter valued at about $33,000. Finally, Banque Transatlantique SA purchased a new stake in shares of CME Group in the 4th quarter valued at approximately $35,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.